All results

34 results for randomized double blind placebo controlled study assess efficacy safety and

• REPLENISH

  The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52…

  Ages

  50 Years - N/A

  Sexes

  All

• Atacicept in Subjects With IgA Nephropathy

  A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3) This is a multi-part study comprising of the original Phase 2b study (active, no…

  Ages

  18 Years - N/A

  Sexes

  All

• Trial of DCA in PDCD

  The objective of this research study is to conduct a pivotal phase 3 trial of treatment with the investigational drug dichloroacetate (DCA) in young children…

  Ages

  6 Months - 17 Years

  Sexes

  All

• TETON

  Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…

  Ages

  40 Years - N/A

  Sexes

  All

• Teton RIN-PF-301

  Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…

  Ages

  40 Years - N/A

  Sexes

  All

• Efficacy and Safety of AMG 570 in Subjects With Active SLE

  The purpose of this study is to determine if Rozibafusp Alfa could be a useful therapeutic agent in the current treatment landscape where subjects with SLE…

  Ages

  18 Years - 75 Years

  Sexes

  All

• RAISE

  This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status…

  Ages

  12 Years - N/A

  Sexes

  All

• Vasomune AV001-004

  A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring…

  Ages

  18 Years - N/A

  Sexes

  All

• ReCePI

  The objective of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery patients based on…

  Ages

  11 Years - N/A

  Sexes

  All

• RECOVER VITAL

  This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community…

  Ages

  18 Years - N/A

  Sexes

  All